Raymond James raises Fulgent Genetics stock price target to $36 on strong performance
Keil Robert, of Finwise Bancorp (NASDAQ:FINW), reported selling 1,500 shares of common stock on November 3, 2025, at a price of $19.48 per share, for a total transaction value of $29,220. The sale comes as FINW shares have seen a significant 36.27% price increase over the past six months and are trading near their 52-week high of $22.49, according to InvestingPro data.
Following the transaction, Keil Robert directly owns 56,428 shares of Finwise Bancorp. The $260.43M market cap company currently trades at a P/E ratio of 17.7 and appears overvalued based on InvestingPro’s Fair Value assessment. For more insights and 6+ additional ProTips on FINW, including cash flow analysis and profitability metrics, check out the comprehensive Pro Research Report available with an InvestingPro subscription.
In other recent news, Finwise Bancorp reported a robust performance for the third quarter of 2025, surpassing both earnings and revenue expectations. The company achieved an earnings per share (EPS) of $0.34, which was above the anticipated $0.30, resulting in a 13.33% surprise. Revenue also exceeded forecasts, reaching $36.66 million compared to the expected $27.87 million, marking a 31.54% surprise. These results highlight Finwise Bancorp’s strong financial position during this period. The company’s stock experienced a modest increase following the earnings announcement. These recent developments reflect positively on Finwise Bancorp’s current financial health. Investors and analysts may find these results indicative of the company’s ongoing performance trends.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.